NewsBenzingaエスピーマニュファクチャリング&エレクトロニクスの第4四半期のEPSは1.15ドルで、0.92ドルの見積もりを上回りました。売上は13.472百万ドルで、14.800百万ドルの見積もりに届きませんでした。 エスピーマニュファクチャリング&エレクトロニクスの第4四半期のEPSは1.15ドルで、0.92ドルの見積もりを上回りました。売上は13.472百万ドルで、14.800百万ドルの見積もりに届きませんでした。 Benzinga 2026.09.23 10:12 (GMT+0) Open on Benzinga Other news Amazon Turns To Former Employees, Including Those Laid-Off, For AI, Cloud Jobs Amid ‘Boomerang’ Hiring Push: Report VEON Announces ~$200M Buyback Plan Kevin O'Leary Explains Why His Big AI Bet is Uranium, Not Big Tech: 'The Trade is Now the Energy Trade' Elon Musk-led SpaceX's Starlink Faces New Military Connectivity Alternative as Boeing Drone Unit Tests Gogo Link Morgan Stanley Maintains Overweight on Celldex Therapeutics, Raises Price Target to $57 Artelo Biosciences Files Provisional Patent Application For ART27.13 As Monotherapy And In Combination With GLP-1 Receptor Agonists
Amazon Turns To Former Employees, Including Those Laid-Off, For AI, Cloud Jobs Amid ‘Boomerang’ Hiring Push: Report
Kevin O'Leary Explains Why His Big AI Bet is Uranium, Not Big Tech: 'The Trade is Now the Energy Trade'
Elon Musk-led SpaceX's Starlink Faces New Military Connectivity Alternative as Boeing Drone Unit Tests Gogo Link
Artelo Biosciences Files Provisional Patent Application For ART27.13 As Monotherapy And In Combination With GLP-1 Receptor Agonists